Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock. A Multicenter, Prospective, Double-blind, Randomized, Placebo-controlled Study

NCT03773822 is registered in ClinicalTrials.gov with CMC Ambroise Paré as lead sponsor.

NCT NCT03773822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03773822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock. A Multicenter, Prospective, Double-blind, Randomized, Placebo-controlled Study
Lead sponsor
CMC Ambroise Paré
Phase
Phase 3
Overall status
Completed
Start date
April 19, 2019
Completion date
April 5, 2023
Enrollment
380 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock